4/A: Tecogen Director Earl R. Lewis Corrects Share Balance After Duplicative Form 4 Filing

Director Earl R. Lewis files an amended Form 4 to correct an overstatement of share balance due to a duplicative filing regarding a purchase of 10,000 shares of Tecogen Inc. (TGEN) common stock.

Summary

• Earl R. Lewis, a director of Tecogen Inc. (TGEN), filed an amended Form 4 with the SEC on March 25, 2025.
• This amendment corrects a previous filing from July 17, 2024, which was duplicative of a Form 4 filed on July 15, 2024.
• Both filings concerned the purchase of 10,000 shares of common stock on July 15, 2024, at a price of $0.68 per share.
• The duplicative filing overstated the share balance owned by Lewis.
• The corrected filing indicates that the balance of shares owned on July 15, 2024, was 625,000 shares, not 635,000 shares as previously reported.

Sentiment

Score: 6

Explanation: The document is a routine correction of a previous filing. While the initial error is a slight negative, the correction itself is a positive sign of compliance.

Negatives

• A duplicative filing led to an overstatement of the director's share balance, requiring a correction.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency and compliance with SEC regulations.

Key Dates

Keywords

Form 4, amendment, share balance, Tecogen, TGEN, Earl R. Lewis, SEC filing, insider trading